AgingResearch.NewsJoin free

Zhejiang Hanmai Pharmaceutical Technology

CompanyChina

Zhejiang Hanmai Pharmaceutical Technology develops one asset, in phase 3 (YJ001 in diabetic peripheral neuropathic pain). Mostly small molecule; based in China.

1
Asset
Furthest stage
Phase 3
1
Trial
2
Signals

Pipeline

1

  • YJ001

    Topical spray formulated for diabetic peripheral neuropathic pain relief

    Phase 3, Small molecule, diabetic peripheral neuropathic pain

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals2
  • Similar companies2

Intelligence